- Measuring the Impact of Opioid Policies -The CDC, FDA, HHS, and Congress all weighed in on opioids, but does it matter?
- New Resource Tool Available from SAMHSA – MATx Mobile App
- How the Opioid Epidemic Is an Infrastructure Issue – Could transitional housing help bring the crisis to a close?
- GOP Zeroes in On Changes to Medicaid
- Psychiatric Conditions Linked to Increased Risk of Long-Term Opioid Use
- What’s Behind the Rise in Cocaine-Linked Deaths? Whether intentional or not, cocaine’s mix with opioids is driving up related deaths.
- Portman Announces Funding for Drug Courts
- Scientists Say They Can Make a Vaccine Against Heroin. It’s an Uphill Battle
- Kaiser Health Tracking Poll: Health Care Priorities for 2017
- Workers Under Employers’ Watch for Opioid Abuse
LINKS TO ADDITIONAL NATIONAL NEWS OF INTEREST
- How an ‘abuse-deterrent’ drug created the heroin epidemic – 1/10/17
- Blog: Here’s How President Trump And Incoming HHS Secretary Tom Price Can End The Nation’s Addiction Crisis – 1/7/17
- President Trump, Scrap the Wall And A Drug War And Treat The Drug Crisis – 1/6/17
- Call in the cuddlers: Volunteers step up to soothe babies born dependent on opioids – 1/6/17
- Syringe Services Programs Face an Uncertain Future in the Trump Era – 1/5/17
- How Patient Satisfaction Surveys Contribute to the Opioid Crisis – 1/2/17
- Dr. Jana Burson Blog: Harm Reduction versus Abstinence Only – 1/2/17
Measuring the Impact of Opioid Policies -The CDC, FDA, HHS, and Congress all weighed in on opioids, but does it matter?
“Policies aimed at curbing the opioid epidemic have been issued by nearly all major federal stakeholders this year: the CDC released opioid prescribing guidelines for physicians; the FDA promoted an opioid ‘action plan;’ HHS raised the prescribing cap on buprenorphine; and the Cures Act earmarked $1 billion for state addiction treatment programs. It may be too early to tell, but in this follow-up story, MedPage Today asks whether this assault against the epidemic is starting to have an impact.”
Source: MedPageToday.com – December 27, 2016
Categories: Addiction, Buprenorphine, Heroin, Medication-Assisted Treatment (MAT), News Updates, OBOT, Opioid Abuse/Addiction, Opioids
Tags: Addiction, Buprenorphine, Heroin, Prescription Opioids, Substance Abuse Treatment
MATx empowers health care practitioners to provide effective, evidence-based care for opioid use disorders. This free app supports practitioners who currently provide medication-assisted treatment (MAT), as well as those who plan to do so in the future.
MATx features include:
- Information on treatment approaches and medications approved by the U.S. Food and Drug Administration for use in the treatment of opioid use disorders
- A buprenorphine prescribing guide, which includes information on the Drug Addiction Treatment Act of 2000 waiver process and patient limits
- Clinical support tools, such as treatment guidelines, ICD-10 coding, and recommendations for working with special populations
- Access to critical helplines and SAMHSA’s treatment locators
The app is available for download at: http://store.samhsa.gov/apps/mat/index.html
Source: SAMHSA – November 29, 2016
Categories: Addiction, Buprenorphine, Heroin, Medication-Assisted Treatment (MAT), Methadone, News Updates, OBOT, Opioid Abuse/Addiction, Opioids, Prescription Drugs
Tags: Addiction, Buprenorphine, Heroin, Methadone Treatment, Prescription Opioids, SAMHSA, Substance Abuse Treatment
How the Opioid Epidemic Is an Infrastructure Issue – Could transitional housing help bring the crisis to a close?
“In 2016, the opioid epidemic in America continued to persist at crisis level: Each day, 91 people died of a drug overdose, and the number of opioid-related deaths has quadrupled since 2000. Rural towns and small cities have been hit especially hard. According to research from the National Institutes of Health, people in non-metropolitan areas have higher rates of drug poisoning deaths, and opioid poisonings in nonmetropolitan counties have increased at more than three times the rate in urban areas.
At the recent HAC Rural Housing Conference, national policymakers proposed a decidedly urban solution to the addition epidemic: infrastructure. Tom Vilsack, the secretary of the U.S. Department of Agriculture, cited a lack of housing as a critical driver and perpetuator of the epidemic. In August, the USDA laid out a plan to finance transitional housing for people in treatment for opioid addiction in 22 states; other speakers called on federal agencies to invest in developing more affordable housing in rural communities.
CityLab spoke with Alan Morgan, the director of the National Rural Health Association, about why housing infrastructure will be a key player in solutions to the opioid epidemic in the years to come.”
Source: CityLab.com – December 27, 2016
See related article: An Addiction Crisis Along ‘The Backbone of America’ available at: https://www.washingtonpost.com/news/to-your-health/wp/2016/12/30/an-addiction-crisis-along-the-backbone-of-america/?utm_term=.18ee79dad57c
“While Democrats have been pounding the drum against proposed changes to Medicare, Republicans appear far more likely to pursue an overhaul of Medicaid, the healthcare program for the poor.
But Republicans warn of the program’s growing costs and have pushed to provide that money to states in the form of block grants — an idea President-elect Donald Trump endorsed during the campaign.”
Source: TheHill.com – December 29, 2016
See related article Obamacare Repeal Jeopardizes Mental Health, Addiction Coverage available at: http://www.usatoday.com/story/news/politics/2017/01/08/obamacare-repeal-jeopardizes-mental-health-addiction-coverage/96199628/
“A wide range of pre-existing psychiatric and behavioral conditions and the use of psychoactive drugs could be important risk factors leading to long-term use of opioid pain medications, reports a study in PAIN®, the official publication of the International Association for the Study of Pain (IASP).
Using a nationwide insurance database, the researchers identified 10.3 million patients who filed insurance claims for opioid prescriptions between 2004 and 2013. The study looked at whether pre-existing psychiatric and behavioral conditions and use of psychoactive medications were predictors of later opioid use.
“We found that pre-existing psychiatric and behavioral conditions and psychoactive medications were associated with subsequent claims for prescription opioids,” write Patrick D. Quinn, PhD, of Indiana University, Bloomington, and colleagues. The association appears stronger for long-term opioid use, and especially for patients with a previous history of substance use disorders.”
Source: Eurekalert.org – December 29, 2016
What’s Behind the Rise in Cocaine-Linked Deaths? Whether intentional or not, cocaine’s mix with opioids is driving up related deaths.
“America’s opioid epidemic is fueling a startling increase in cocaine-related overdose deaths in recent years, as users mix deadly cocktails involving the stimulant that had otherwise shown encouraging signs of stalling impact, according to a U.S. News analysis of mortality data.
The findings raise serious concerns about the extent to which drug users are mixing cocaine, which can result in overdose on its own, with even more deadly drugs like heroin and fentanyl, a strong synthetic opioid. It also raises questions about whether people are mixing the drugs intentionally or are falling victim to tainted products.”
Source: USNews.com – January 3, 2017
“U.S. Senator Rob Portman (R-OH) has announced that funding authorized as part of his bipartisan Comprehensive Addiction & Recovery Act (CARA)—which President Obama signed into law—for establishing or enhancing drug courts and veterans courts is now available.
Under CARA, the U.S. Department of Justice is now seeking applications to establish or enhance drug court services, including treatment and recovery support services for states and local communities.”
Source: CirclevilleHerald.com – January 7, 2017
“Researchers in California have successfully tested a heroin vaccine on monkeys and have shown vaccines against fentanyl, oxycodone, and hydrocodone to be viable in rodents. Another team in Maryland has successfully tested a heroin vaccine on rodents.
With proper funding, both groups say, they could get their vaccines into human trials within two years.
As promising as the concept sounds, the vaccines are no panacea. They would be effective only for those who were deeply committed to recovery, and wouldn’t seek another kind of drug. Experts say that if they succeed, they would complement other available therapies.”
Source: Philly.com – January 6, 2017
“The latest Kaiser Health Tracking Poll finds that health care is among the top issues, with the economy and jobs and immigration, Americans want President-elect Donald Trump and the next Congress to address in 2017. When asked about a series of health care priorities for President-elect Trump and the next Congress to act on, repealing the ACA falls behind other health care priorities including lowering the amount individuals pay for health care, lowering the cost of prescription drugs, and dealing with the prescription painkiller addiction epidemic.
When presented with two general approaches to the future of health care in the U.S., six in ten (62 percent) Americans prefer “guaranteeing a certain level of health coverage and financial help for seniors and lower-income Americans, even if it means more federal health spending and a larger role for the federal government” while three in ten (31 percent) prefer the approach of “limiting federal health spending, decreasing the federal government’s role, and giving state governments and individuals more control over health insurance, even if this means some seniors and lower-income Americans would get less financial help than they do today.”
Source: KFF.org – January 6, 2017
“More than a quarter of employers have examined the prescription drug claims of its employees to identify possible opioid abuse, and another 25 percent are considering such measures, according to a new survey from the International Foundation of Employee Benefit Plans.
Of organizations providing substance abuse treatment benefits, 89 percent cover outpatient in-person treatment sessions, and 85 percent include inpatient hospital or clinic treatment. Other commonly provided options include prescription drug therapies (67 percent), inpatient residential treatment centers (67 percent), outpatient telemedicine treatment services (55 percent) and referrals to community services (41 percent).”
Source: DaytonDailyNews.com – January 9, 2017
Categories: News Updates